2 Neuroscience2.9 Genetics
2.9.3 Genetic abnormalities, inherited conditions and clinical genetics
17 min read7 figures
Written by Resident Doctor Committee · Published
Chromosome structure
Type | Centromere | Note |
|---|---|---|
Metacentric | Central, so the arms are equal | A Robertsonian translocation produces one |
Submetacentric | Partly displaced | Arms unequal |
Acrocentric | Near one end, with a very short but present p arm | Chromosomes 13, 14, 15, 21 and 22 |
Telocentric | At the very end, with no p arm | Does not occur in the normal human karyotype |
Acrocentric is told from telocentric by the p arm: acrocentric has a tiny one, telocentric has none.
Rearrangement | What happens | Consequence |
|---|---|---|
Deletion | A segment is lost | Lower dosage across the interval |
Duplication | A segment gains an extra copy | Higher dosage, and the breakpoint may disrupt a gene |
Inversion | A segment is reversed in place | The carrier is balanced but makes unbalanced gametes |
Insertion | A segment moves elsewhere | Gene disruption or altered dosage |
Balanced translocation | Segments exchange with no net loss | Healthy carrier, unbalanced gametes |
Unbalanced translocation | Net gain or loss | Phenotype of the missing or extra region |
Ring chromosome | Both ends are lost and the arms join | Dosage loss and instability at mitosis |
A Robertsonian translocation joins the long arms of two acrocentric chromosomes (for example 13 and 14) at the centromere into one metacentric chromosome, and the gene-poor short arms are lost.
A balanced Robertsonian carrier, such as a 14;21 carrier, is healthy but has a real risk of having a child with translocation Down syndrome.
Copy number variants are deletions or duplications that change gene dosage, and apparently balanced breakpoints can still disrupt genes.
Numerical abnormalities and mosaicism
Aneuploidy is a gain or loss of whole chromosomes, as in the trisomies (trisomy 21 adds a whole chromosome) and the sex chromosome aneuploidies.
Deletions, single-gene changes and imprinting defects leave the count at 46, so they are not aneuploidy.
Triploidy is a complete extra haploid set, 69 chromosomes, and is a typical cause of early pregnancy loss.
Complete autosomal monosomy does not allow survival, but 45,X can.
Nondisjunction is failed separation of homologues at meiosis I or of sister chromatids at meiosis II.
Trisomy changes chromosome dosage without necessarily altering the DNA sequence.
Timing of nondisjunction | Result |
|---|---|
Meiosis, before fertilisation | Every cell of the zygote is affected |
Early mitotic division after fertilisation | Mosaic trisomy, with normal and trisomic cell lines |
Mosaicism often gives variable severity, and a blood test can miss mosaicism confined to other tissues.
X-inactivation
Lyonisation (X-inactivation) silences one X early in development in any cell holding more than one X chromosome, so it shapes the phenotype in conditions with a surplus X, such as XXY.
The inactive X is condensed in female somatic nuclei as a Barr body.
Random X-inactivation makes a heterozygous female a functional mosaic, so she is usually less affected than a hemizygous male by an X-linked variant, as in fragile X syndrome.
Skewed X-inactivation silences the normal X in most cells, so a female carrier of an X-linked variant, including a fragile X full mutation, can express the disorder.
Mendelian inheritance
Pattern | Risk to children | Pedigree clue |
|---|---|---|
Autosomal dominant | 50% for each child of an affected heterozygote and an unaffected partner, whatever the sex | Every generation, both sexes, father-to-son transmission; Huntington's disease, Noonan syndrome (PTPN11, SOS1, KRAS) |
Autosomal recessive | 1 in 4 per child from two unaffected carriers | No vertical transmission; affected children of both sexes born to unaffected parents; cystic fibrosis |
X-linked recessive | All daughters of an affected man are obligate carriers | Only males affected, passed through unaffected carrier women, no male-to-male transmission |
X-linked dominant | An affected father passes it to all daughters and no sons; an affected mother to children of both sexes | No male-to-male transmission |
Y-linked | A father passes it to every son and no daughter | His daughters are not carriers |
Mitochondrial | Affected women pass it to all their children | Never passed on by affected men |
Father-to-son transmission rules out X-linkage, because a father passes his Y to every son and his only X to every daughter.
Autosomal recessive inheritance seems to skip generations because heterozygous carriers are unaffected, and the trait is absent from earlier generations.
Consanguinity raises the chance that both parents carry the same rare recessive allele.
When both parents have the same autosomal recessive condition, both are homozygous, so every child is affected (1 in 1, not 1 in 4).
The knight's move of X-linked recessive inheritance runs from an affected man through his carrier daughter to an affected grandson; in Duchenne muscular dystrophy it shows as affected brothers, a carrier mother and an affected maternal uncle.
Enzyme and storage disorders are generally autosomal recessive, but acute intermittent porphyria (HMBS gene, porphobilinogen deaminase) is autosomal dominant.
Hunter syndrome (mucopolysaccharidosis type II, iduronate sulfatase deficiency) and Lesch-Nyhan syndrome are X-linked recessive, whereas Hurler syndrome (type I) is autosomal recessive.
Mitochondrial inheritance
Heteroplasmy means cells carry unequal loads of mutant mitochondrial DNA, and disease appears only above a tissue threshold, so children of one mother differ in severity and some escape disease.
Leber's hereditary optic neuropathy is a mitochondrial, purely maternally inherited condition.
MELAS gives stroke-like episodes outside arterial territories, seizures and raised lactate, and is usually caused by m.3243A>G in mitochondrial DNA.
Penetrance, expressivity and imprinting
Penetrance is whether a carrier shows the phenotype at all, so an unaffected carrier shows incomplete penetrance.
Expressivity is how severely or in what form the phenotype shows, so differing severity among affected carriers of one variant is variable expressivity.
Genomic imprinting makes expression of an allele depend on the sex of the parent it came from, so the same variant causes disease from one parent and stays silent from the other.
Uniparental disomy gives both copies of a chromosome from one parent, with a normal chromosome count.
Sequence variants and repeat expansion
Variant | Effect |
|---|---|
Missense | One amino acid is substituted |
Nonsense | A premature stop gives a truncated protein or a degraded transcript |
Splice | An exon is skipped or an intron retained |
Frameshift insertion or deletion | A change that is not a multiple of three alters every downstream codon, usually with an early stop |
Repeat expansion | A short repeat gains copies and lengthens between generations |
Dynamic mutations are unstable trinucleotide repeat expansions that change size between generations.
Repeat expansion is one mutation class shared by clinically unrelated disorders, such as fragile X syndrome and Huntington's disease.
Each repeat disorder expands its own repeat unit in its own gene, so the repeat motif identifies the disease.
Anticipation is progressively earlier onset and greater severity in successive generations, classically from unstable trinucleotide repeat expansion.
Anticipation differs from variable expressivity, which has no generational trend.
Repeat disorders differ from contiguous-gene microdeletion syndromes, which are copy number changes without anticipation.
Disorder | Repeat, gene, locus | Inheritance | Repeat expands mainly through |
|---|---|---|---|
Huntington's disease | CAG, HTT, 4p16.3 | Autosomal dominant | Father |
Fragile X syndrome | CGG, FMR1, Xq27.3 | X-linked | Mother |
Myotonic dystrophy type 1 | CTG, DMPK, 19q13 | Autosomal dominant | Mother |
Friedreich's ataxia | GAA in intron 1, frataxin (FXN), 9q21 | Autosomal recessive | No anticipation |
Myotonic dystrophy type 1 gives grip myotonia, frontal balding, apathy and hypersomnia, and its congenital form follows maternal transmission of a large expansion.
In Friedreich's ataxia the expansion lowers frataxin production.
Spinocerebellar ataxia type 3 (Machado-Joseph disease, described in Azorean families) is a CAG expansion in ATXN3 that adds a polyglutamine tract and shows anticipation.
Huntington's disease
Huntington's disease is an expanded CAG repeat in HTT (huntingtin) at 4p16.3.
The pathological threshold is about 36 repeats: 36 to 39 show reduced penetrance and 40 or more are fully penetrant.
The CAG repeat is translated into a long polyglutamine tract, giving huntingtin a toxic gain of function, unlike the gene silencing of fragile X.
It presents in mid-life with chorea, subcortical cognitive decline and irritability, and mood, behavioural or psychotic symptoms may come before the movement changes.
Inheritance is autosomal dominant, so the family history is the most important part of the history.
Anticipation follows meiotic expansion of the unstable repeat, and a longer repeat brings earlier onset.
The repeat is least stable when a father passes it on, so anticipation and juvenile onset are most marked with paternal transmission, while maternal transmission keeps length fairly stable.
Juvenile disease often has rigidity and seizures.
Down syndrome
Trisomy 21 is the commonest trisomy compatible with survival to birth, about 1 in 700 births, and its risk rises with maternal age.
Form | Share | Cause | Recurrence |
|---|---|---|---|
Free trisomy 21 | About 95% | Meiotic nondisjunction in either parent, mostly the mother | Sporadic |
Robertsonian translocation | About 4% | Two acrocentrics, such as 14 and 21, fused at the centromere | Can be passed on by an unaffected balanced carrier of either sex |
Mosaic | About 1% | Error after fertilisation | Sporadic |
Mosaic Down syndrome is milder in cognition and physique than the other forms, because normal cell lines dilute the dosage effect.
Parental karyotyping is needed only for the translocation form.
Signs include intellectual disability, Brushfield spots and a sandal gap.
Endocardial cushion (atrioventricular septal) defect is the commonest congenital heart lesion.
APP (amyloid precursor protein), encoded on chromosome 21, is cleaved by beta-secretase then gamma-secretase; trisomy raises its dose by half, so almost everyone with Down syndrome has plaques by 40.
Edwards and Patau syndromes
Feature | Edwards syndrome | Patau syndrome |
|---|---|---|
Karyotype | Trisomy 18, a free extra whole 18 | Trisomy 13, an extra whole 13 |
Features | Clenched fist with overlapping fingers | Holoprosencephaly, cleft lip and palate, postaxial polydactyly, small eyes, congenital heart disease |
Survival | Most liveborn infants die within the first year | Most liveborn infants die within the first year |
Edwards (18) is told from Patau (13) and Down (21) by which chromosome is extra.
Patau syndrome is more frequent with older mothers.
A minority of Patau cases arise from a Robertsonian translocation carrying the long arm of a third chromosome 13, so the count stays at 46.
Sex chromosome aneuploidies
Condition | Karyotype and origin | Physical features | Cognition and behaviour |
|---|---|---|---|
Klinefelter syndrome | 47,XXY from meiotic nondisjunction in either parent; sporadic, not passed down families | Tall; small firm testes, raised gonadotrophins, absent sperm, gynaecomastia, sparse facial hair | Usually normal intelligence; reading and spelling difficulties |
47,XYY | Nondisjunction; often unrecognised | Tall; normal testes, hormones, puberty and fertility | Mostly normal intelligence; more speech delay and learning problems |
Triple X | 47,XXX | Normal puberty and fertility | Usually mild |
Turner syndrome | 45,X or partial loss of one X; sporadic | Short stature, webbed neck, low posterior hairline, broad shield chest, increased carrying angle, lymphoedema of hands and feet, ovarian failure | Normal intelligence with a specific visuospatial weakness |
Klinefelter syndrome is primary testicular failure.
47,XYY is usually clinically silent, and was historically labelled the "super-male".
A 1965 secure hospital survey linked XYY with aggression and antisocial behaviour, but the association is modest.
XYY is told from Klinefelter, XXYY and XX male by its normal testes: those three cause small testes and azoospermia.
Turner syndrome is the only monosomy compatible with life, and affects only females because no Y directs male development.
The single X in 45,X is usually maternal, so the lost chromosome is usually paternal.
The webbed neck comes from fetal lymphatic obstruction.
Because Turner syndrome is a sporadic error, the recurrence risk in a later pregnancy is not appreciably raised.
Fragile X syndrome
Fragile X syndrome is the commonest inherited cause of learning disability.
It is caused by expansion of a CGG repeat in the 5' untranslated region of FMR1 at Xq27.3.
Allele | CGG repeats | Consequence |
|---|---|---|
Premutation | 55 to 200 | Its own disorders through RNA toxicity, not the full syndrome |
Full mutation | Over 200 | Methylation switches FMR1 off, and loss of its protein, FMRP, causes fragile X |
The premutation disorders are FXTAS, a late-onset tremor and ataxia chiefly in men, and primary ovarian insufficiency, affecting about 20% of female carriers.
A premutation expands to a full mutation mainly when a woman passes it on, because instability arises in female meiosis; fathers pass on only premutation-sized alleles.
Fragile X is conventionally classed as X-linked dominant with reduced penetrance and shows an X-linked pedigree.
The physical signs are a long narrow face, large protruding ears, joint laxity, tall stature and macroorchidism (large testes after puberty), and they are understated before puberty.
Behaviour includes gaze aversion, social anxiety, hand flapping, sensory hypersensitivity, autistic features and inattention, with mild intellectual disability.
Speech is cluttered: fast, uneven in rate and repetitive.
The 15q11-q13 imprinting disorders
Prader-Willi and Angelman syndromes are mirror images at the same imprinted region, and every mechanism below is a parent-of-origin effect.
Feature | Prader-Willi syndrome | Angelman syndrome |
|---|---|---|
Copy lost | Paternal | Maternal |
Genes | Paternally expressed genes such as SNRPN and MAGEL2 | UBE3A, expressed in neurons only from the maternal allele |
Mechanisms | Paternal deletion (about 70%), maternal uniparental disomy (about 25%), imprinting centre defect | Maternal deletion, paternal uniparental disomy, imprinting defect, UBE3A mutation |
Prader-Willi syndrome
It starts with neonatal hypotonia and poor feeding, followed from early childhood by relentless food seeking.
Hyperphagia and obesity are the defining behavioural feature.
Other features are intellectual disability, small hands and feet, and compulsive skin picking.
Short stature comes largely from growth hormone deficiency.
Hypogonadism gives small or undescended gonads and delayed, incomplete puberty.
Angelman syndrome
People have a happy, excitable manner with frequent, easily provoked laughter, severe learning disability, absent speech and ataxia.
Seizures occur in over 80%, usually starting between one and three years, and a distinctive electroencephalogram (EEG) pattern is well established by about two years.
Microdeletion syndromes
Syndrome | Deletion | Features |
|---|---|---|
22q11.2 deletion (DiGeorge, velocardiofacial) | 22q11.2, about 1 in 4,000 | Conotruncal or aortic arch heart defects, palatal insufficiency with hypernasal speech, immune problems, neonatal hypocalcaemia from parathyroid hypoplasia, learning disability |
Williams syndrome | 7q11.23, de novo, including the elastin gene | Supravalvular aortic stenosis, infantile hypercalcaemia, elfin facies, hoarse voice, hyperacusis, mild intellectual disability |
Smith-Magenis syndrome | 17p11.2, usually including RAI1 (otherwise an RAI1 point mutation) | Inverted melatonin rhythm with broken night sleep and daytime sleepiness, self-hugging when excited, nail pulling, pushing objects into body openings |
Cri du chat syndrome | Distal short arm of 5 (5p minus), critical region 5p15 | High-pitched cat-like cry in infancy from an abnormal larynx, microcephaly, round face, hypertelorism, severe learning disability |
Phelan-McDermid syndrome | 22q13.3, removing one copy of SHANK3 | Severe speech delay, hypotonia, autistic features |
Wolf-Hirschhorn syndrome is a terminal deletion of the short arm of chromosome 4, with its critical region at 4p16.3.
Hypocalcaemia belongs to 22q11.2 deletion and hypercalcaemia to Williams syndrome.
22q11.2 deletion has the strongest psychiatric link with schizophrenia and related psychosis, affecting about one in four adults.
This is a 25 to 30-fold risk, the largest known single genetic risk, exceeded only by having a monozygotic co-twin with the illness.
The elastin deletion explains the supravalvular aortic stenosis of Williams syndrome.
In Williams syndrome, expressive language is relatively good and speech fluent but shallow, while visuospatial skills are markedly weak.
Indiscriminate hypersociability towards strangers in Williams syndrome sits over impaired social reciprocity.
SHANK3 is a scaffold protein of the excitatory postsynaptic density.
Cri du chat is a structural loss of chromosomal material, not a change in chromosome count.
Rett syndrome
Rett syndrome is caused by mutation of MECP2 (methyl-CpG-binding protein 2) at Xq28, which accounts for nearly all classic cases.
It is X-linked dominant.
It is seen almost only in girls because the mutation is usually lethal early in hemizygous boys.
It almost always arises as a new mutation, mainly in sperm, and a father passes his X only to daughters.
A girl develops normally at first and then regresses, losing purposeful hand use and speech, with social withdrawal.
Regression comes with midline hand-wringing stereotypies, gait change, breathing irregularities and slowing head growth.
Regression also occurs in autism, so regression alone does not separate the two.
Single-gene metabolic and neurological disorders
Condition | Gene and inheritance | Mechanism | Presentation |
|---|---|---|---|
Lesch-Nyhan syndrome | HPRT1 at Xq26-q27; X-linked recessive | HPRT (HGPRT) deficiency, causing urate overproduction | Dystonia and compulsive self-biting that distresses the child |
Phenylketonuria | Phenylalanine hydroxylase gene on chromosome 12; autosomal recessive | Phenylalanine hydroxylase deficiency | Untreated: severe learning disability, seizures, musty odour; newborn screening and a low-phenylalanine diet prevent it |
X-linked adrenoleukodystrophy | ABCD1; X-linked recessive | Raised very long chain fatty acids | Behavioural decline in boys, then motor and visual loss with adrenal failure; adrenomyeloneuropathy is the milder adult form |
Wilson disease | Biallelic ATP7B on chromosome 13; autosomal recessive | Impaired copper excretion into bile | Teenage tremor, dysarthria and behavioural change, with liver disease |
Niemann-Pick type C | NPC1 or NPC2; autosomal recessive | Lysosomal storage from faulty cholesterol trafficking | Psychosis with vertical supranuclear gaze palsy and ataxia in a young adult |
CADASIL | NOTCH3 on chromosome 19; autosomal dominant | Small vessel arteriopathy | Migraine with aura, early lacunar strokes, mood disorder, vascular dementia; white matter change in the anterior temporal lobes and external capsule |
Kallmann syndrome | ANOS1; X-linked | Gonadotrophin-releasing hormone neurones fail to migrate | Hypogonadotrophic hypogonadism with anosmia |
Niemann-Pick disease types A and B are caused by acid sphingomyelinase deficiency, so sphingomyelin builds up in lysosomes.
In Wilson disease, copper in Descemet's membrane forms a Kayser-Fleischer ring.
Wilson disease gives low caeruloplasmin, low total serum copper and high 24-hour urinary copper.
Wilson disease is treatable, so it is considered whenever behavioural, liver and movement changes start young.
Neurocutaneous syndromes
Feature | Neurofibromatosis type 1 | Tuberous sclerosis complex |
|---|---|---|
Inheritance | Autosomal dominant | Autosomal dominant with variable expression |
Gene | NF1 on chromosome 17 (NF2 is on chromosome 22) | TSC1 at 9q34 (hamartin) or TSC2 at 16p13.3 (tuberin), which together inhibit mTOR |
Skin and eye | Café-au-lait macules, axillary and skinfold freckling, neurofibromas, Lisch nodules | Ash-leaf macules, facial angiofibromas, shagreen patches |
Neurological | Optic pathway glioma | Seizures, developmental delay or intellectual disability |
Psychiatric presentation | Attention, learning or mood difficulties | Autism is common |
Lisch nodules are small raised tan hamartomas of the iris, seen in most adults with neurofibromatosis type 1.
Complex inheritance and risk genes
Single-gene disorders explain a minority of psychiatric presentations, and common psychiatric disorders mainly reflect susceptibility spread across many variants.
Schizophrenia is complex and polygenic, with heritability about 60 to 80%, more than 100 common risk loci, rarer copy number variants, and familial clustering without a Mendelian pattern.
Rare large-effect copy number variants, such as 22q11.2 deletion, are enriched in schizophrenia with intellectual deficit.
Rare copy number variants, including de novo deletions and duplications, are more strongly and consistently associated with autism spectrum disorder than with attention deficit hyperactivity disorder.
High-risk copy number variants can cross psychotic, developmental and physical phenotypes.
Gene | Product | Link to disease |
|---|---|---|
APOE epsilon 4 | Apolipoprotein E variant | Strongest common genetic risk for late-onset Alzheimer's disease; each copy adds risk and brings onset earlier; neither necessary nor sufficient |
PSEN1 on chromosome 14 | Presenilin 1, the catalytic core of gamma-secretase | Commonest cause of autosomal dominant early-onset Alzheimer's disease, by raising amyloid-beta 42 |
GRN on chromosome 17 | Progranulin | Loss-of-function mutations cause familial frontotemporal dementia with TDP-43 pathology |
KCNH2 (hERG) | Pore-forming subunit of the IKr current | Citalopram and haloperidol block it to lengthen the QT interval; loss of function causes long QT syndrome type 2 |
APP and PSEN2 also cause dominant early-onset Alzheimer's disease, and MAPT and C9orf72 also cause familial frontotemporal dementia.
Genetic testing and prenatal diagnosis
Test | Detects | Misses |
|---|---|---|
Karyotype | Aneuploidy, large structural change, balanced rearrangement | Submicroscopic and sequence variants |
Chromosomal microarray | Genome-wide submicroscopic deletions and duplications | Balanced rearrangements, repeat expansions and sequence variants; it also returns variants of uncertain significance |
Targeted molecular test | A named familial variant, repeat or locus | Anything outside the question asked |
Screening estimates probability, whereas diagnosis tests for specified abnormalities.
Combined screening uses nuchal translucency, serum markers and background risk.
Maternal cell-free DNA mainly samples placental fragments, so a high-chance result needs diagnostic confirmation before any irreversible decision.
Chorionic villus sampling takes placenta from about 11 weeks, and confined placental mosaicism can complicate it.
Amniocentesis takes amniotic fluid from about 15 weeks.
Either procedure adds a miscarriage risk of roughly 0.1 to 0.5%.
A normal result excludes only the abnormalities the test can detect.
Genetic counselling and DNA banks
Counselling starts from the person's question, phenotype and pedigree, and explains inheritance, probabilities, mosaicism, penetrance and test limits before testing.
The counsellor supports informed choice without steering testing or reproductive decisions.
Predictive testing may come decades before symptoms, so psychological state and suicide risk are assessed.
Carrier and prenatal testing concern reproductive decisions.
A variant of uncertain significance cannot by itself establish predictive risk.
Clinician and patient agree in advance which incidental findings will be returned.
Positive and negative results can both bring distress, relief, guilt and changed plans.
Counselling covers what a result means for relatives and encourages disclosure to them while protecting confidentiality.
Psychiatry assesses capacity, mental state and psychological response, while genetics services bring expertise in inheritance and testing.
Clinical DNA banks keep samples for later family testing, whereas research biobanks link samples with health data.
Biobank consent covers access, linkage, commercial use, withdrawal and returned findings.
De-identification cannot remove the risk that a genome identifies its owner.